GHM

69.9409.56%
JJ

James Joseph Barber

Independent Director

Dr. James Joseph Barber, also known as Jim, Ph.D. has been an Independent Consultant and the Principal of Barber Advisors, LLC since September 2007. He is Executive Chairman of Segetis, Inc. He serves as Director of Gevo, Inc since May 21, 2025 and served as its Advisor. He served as the President and Chief Executive Officer of Metabolix, Inc. from January 2000 to May 3, 2007 which Dr. Barber joined in 2000. During this period, he led the transformation of Metabolix from a research boutique to a world renowned, highly regarded leader in clean tech and industrial biotechnology, building it into a multi-disciplinary, industry leading, publicly traded enterprise. He negotiated a highly attractive joint venture arrangement with Archer Daniels Midland for commercialising Metabolix's first product platform, Mirel natural plastics. He was responsible for transforming Metabolix from a research boutique into a leader in clean tech and industrial biotechnology. He negotiated a highly attractive joint venture arrangement with Archer Daniels Midland for commercializing Metabolix’s first product platform, MirelTM natural plastics and took it public in November 2006. He has substantial executive level leadership experience and a deep understanding of product and business development in highly technical industries and alternative energy markets. Dr. Barber also has significant experience in structuring both joint venture and acquisition transactions. Dr. Barber served as an Executive Director of Metabolix, Inc. from January 2000 to May 3, 2007. Prior to Metabolix in 2000, he served as Global Business Director for the organometallics and catalysts business at Albemarle Corporation from September 1993 to January 2000. He served as the President of Geltech Inc. and Chief Operating Officer of Hyperion Catalysis International. From March 1992 until September 1993, he served as Director of Business Development at Ethyl Corporation where he was responsible for acquisitions and managed venture capital activities. Dr. Barber was the Chairman of the Board at Allylix, Inc. since May 2013 and was its Director since May 2012 through December 2014. He has been an Independent Director of Graham Corporation since 2011. He served as a Director of Agrivida, Inc. since November 2010 through December 2014. He also served as a Director of Itaconix Corporation from 2012 until 2016. He was an Executive Director of Segetis, Inc. since July 2012 through February 2016. He has been Member of Advisory Board at Proterro, Inc., since September 2013. He was Independent Non-Executive Director at Itaconix PLC since November 2018 until July 05, 2022. He served as Independent Non-Executive Chairman of Itaconix PLC since December 21, 2018 until July 05, 2022. He was a Non Executive Director at Itaconix plc (formerly, Revolymer plc) since September 12, 2016 until November 2018 and served as its Non-Executive Chairman since December 1, 2018 until January 2019. He served as Independent Director at Nanocomp Technologies, Inc since February 2014 until February 2018. He served as a Member of Advisory Board of P2 Science, Inc. He served as a Member of Scientific Advisory Board (Advisor) of Solazyme, Inc. He served as a Director of Codon Devices from August 2008 to March 2009, Itaconix, Inc., a private company, from June 2014 through June 2016 and Bluewater Holdings Corp. from February 2008 to November 2010. From June 2008 to August 2009, he served as the acting Executive Director of Diagnostics for all, a not-for-profit company. He served as Representative Director of Nippon Aluminum Alkyls. He serves on the Advancement Council of the College of Polymer Science and Polymer Engineering at the University of Akron. He received the American Chemical Society's Henry F. Whalen, Jr. award for Business Development in September 2003. Dr. Barber received a B.S. in Chemistry from Rensselaer Polytechnic Institute in 1976 and a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology in 1980. Dr. Barber had been a Consultant of TerraVia Holdings, Inc. (f/k/a Solazyme, Inc). since April 2008. He served as a Member of Scientific Advisory Board at TerraVia Holdings, Inc.

Positions